Blog Archive
-
▼
2008
(66)
-
▼
April
(10)
- Hybrigenics : Significant progress in cancer-relat...
- GENFIT : encouraging results in GFT505 first clini...
- Diatos : Pre-Clinical Results in Clinical Cancer R...
- BioAlliance Pharma Expands Its Loramyc Franchise
- PerkinElmer and Cerep : Partners for Custom Drug D...
- bioMerieux : Collaboration with University of Sun...
- GenOdyssee : Notice of Allowance from U.S. Patent ...
- LDR : Two-Level Cervical Disc Study Enrollment in ...
- MacoPharma : THERAFLEX Methylene Blue (MB)-Plasma
- genOway : Master service agreement with Boehringer...
-
▼
April
(10)
Wednesday, April 2, 2008
genOway : Master service agreement with Boehringer Ingelheim Pharmaceuticals Inc.
Lyon, France - March 2008 - genOway, the biotechnology company dedicated to the development of genetically modi•ed animal models reports the signing of a master service contract with Boehringer Ingelheim Pharmaceuticals Inc. This agreement is a master service agreement under which genOway will provide its client with customized mouse and rat lines tailored to the researchers' needs. The agreement is a 5-year agreement... genOway 's Press Release -